SECAUCUS, N.J. and INDIANAPOLIS, Sept. 12, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information se

LEXINGTON, Mass., Sept. 12, 2019 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced the promotion of Bill Steinkrauss to Chief Financial Officer. Mr. Steinkrauss joined Curis in August 2016 and mo

TEL AVIV, Israel and BETHESDA, Maryland, Sept. 12, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC-QB: CNBX), a leader in personalized cannabis based cancer medicine, today announced that its Scientific Director, Dr.

LA JOLLA, Calif., Sept. 12, 2019 /PRNewswire/ -- Avidity Biosciences, a privately-held biotechnology company pioneering Antibody Oligonucleotide Conjugates (AOCs™), today announced that Arthur A. Levin, Ph.D., Chief Scientific Officer, is scheduled to present at the 2019 Myotonic Annual Conference on Saturd

LA JOLLA, Calif., Sept. 12, 2019 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of in

SAN DIEGO, Sept. 12, 2019 /PRNewswire/ -- Aristea Therapeutics (Aristea), a clinical-stage drug development company developing novel therapies to treat serious inflammatory diseases, today announced the formation of its Scientific Advisory Board (SAB), which is comprised of industry experts in inflammatory and dermatological disease drug development.  The SAB w

WASHINGTON, Sept. 12, 2019 /PRNewswire/ -- International Leaders Summit (ILS), a US-based think tank, will host the inaugural US-India Leaders Summit at The National Press Club in Washington, DC on September 18, 2019, to advance policies addressing healthcare, trade and security. Speakers include Dr.

SAN DIEGO, Sep. 12, 2019 /PRNewswire/ -- NI Research is pleased to announce that the September/October issue of NeuroPerspective has been released. It features our 

ROANOKE, Va., Sept. 12, 2019 /PRNewswire/ -- Hollins Communications Research Institute (HCRI), a national center for stuttering research and therapy innovation, just completed another research initiative in collaboration with the National Institutes of Health (NIH). The study is the first to evaluate stuttering therapy outcomes among a group of stutterers who possess one

KELOWNA, BC, Sept. 12, 2019 /PRNewswire/ - Valens GroWorks Corp. (TSXV: VGW) (OTCQX: VGWCF) (the "Company" or "Valens"), a vertically integrated provider of industry leading extraction products and services; including a diverse suite of extraction methodologies, next generation cannabinoid delivery formats and an ISO 17025 accredited analyt